ABOUT US
LEADERSHIP
BOARD OF DIRECTORS
SCIENTIFIC BOARD
OUR SCIENCE
GENENTA PLATFORM
CELL THERAPY
LENTIVIRUS
TME & TEMs
TEMFERON™
SCIENTIFIC PUBLICATIONS
OUR PIPELINE
INVESTOR
NEWSROOM
PRESS RELEASES
PRESS COVERAGE
GALLERY CEREMONY
PARTNERS
CONTACT
Select Page
FierceBiotech
2017-01-19_FierceBiotech-Ex-GSK-rare-disease-head-moves-to-Genenta
Back
Pin It on Pinterest